PT  - JOURNAL ARTICLE
AU  - F. Gatto
AU  - P. Ueda
TI  - Causal effects of senescence through intrinsic epigenetic age acceleration on age-related diseases: a Mendelian randomization study
AID  - 10.1101/2020.04.27.20081406
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.27.20081406
4099  - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20081406.short
4100  - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20081406.full
AB  - Older age is associated with many diseases. However, it is unclear whether the biological mechanisms underpinning senescense (biological ageing) is a cause of age-related diseases (ARDs). In this Mendelian randomization study, we examined the causal effects of intrinsic epigenetic age acceleration (IEAA) - a process assumed downstream of senescence - on the occurrence of ARDs. In a metanalysis of 18 genome-wide association studies (GWAS) spanning 12 ARDs in ~27 million people of European ancestry (median per GWAS: 17’008 cases vs. 40’940 controls), IEAA-associated SNPs did not significantly increase the risk of ARDs as a group (odds-ratio (OR) = 0.99) nor of any individual ARD (OR range: 0.87-1.04). However, one SNP, rs2736099 on TERT, was significantly associated with 8 of 10 ARDs with increased risk for lung and ovarian cancer, atrial fibrillation, and benign prostatic hyperplasia and lower risk for Alzheimer’s disease, rheumatoid arthritis, cardiovascular artery disease and breast cancer. No associations between rs2736099 and known ARD risk factors were found strengthening the causal role of rs2736099-associated senescence. While IEAA was not found as a unifying cause of ARDs, senescence seems to cause some ARDs while preventing others through a mechanism only partially affecting IEAA and associated with rs2736099.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study received no specific funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnalyses in this study can be accessed at https://github.com/gattofr/SenescenceMR https://github.com/gattofr/SenescenceMR